Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial.

Jesam C, Salvatierra AM, Schwartz JL, Fuentes A, Croxatto HB.

Contraception. 2014 Aug;90(2):168-73. doi: 10.1016/j.contraception.2014.04.011. Epub 2014 May 5.

PMID:
24909636
2.

Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception.

Jesam C, Salvatierra AM, Schwartz JL, Croxatto HB.

Hum Reprod. 2010 Feb;25(2):368-73. doi: 10.1093/humrep/dep392. Epub 2009 Nov 19.

3.
4.

Delay of ovulation by meloxicam in healthy cycling volunteers: A placebo-controlled, double-blind, crossover study.

Bata MS, Al-Ramahi M, Salhab AS, Gharaibeh MN, Schwartz J.

J Clin Pharmacol. 2006 Aug;46(8):925-32.

PMID:
16855077
5.

Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.

Brache V, Cochon L, Deniaud M, Croxatto HB.

Contraception. 2013 Nov;88(5):611-8. doi: 10.1016/j.contraception.2013.05.010. Epub 2013 May 22.

PMID:
23809278
6.

Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.

Croxatto HB, Massai MR, Salvatierra AM, Fuentealba B, Croxatto HD, Lähteenmäki P.

Contraception. 1996 Aug;54(2):79-86.

PMID:
8842583
9.

Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.

Cameron ST, Thong KJ, Baird DT.

Clin Endocrinol (Oxf). 1995 Oct;43(4):407-14.

PMID:
7586613
10.
11.
12.

Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.

Barbosa I, Coutinho E, Hirsch C, Ladipo O, Olsson SE, Ulmsten U.

Fertil Steril. 1996 Apr;65(4):724-9.

PMID:
8654629
13.

Shorter pill-free interval in combined oral contraceptives decreases follicular development.

Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, Düsterberg B.

Contraception. 1996 Aug;54(2):71-7.

PMID:
8842582
14.

Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.

Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.

Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):779-87.

PMID:
7573244
15.
16.

Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women.

Edelman AB, Jensen JT, Doom C, Hennebold JD.

Contraception. 2013 Mar;87(3):352-7. doi: 10.1016/j.contraception.2012.07.004. Epub 2012 Aug 16.

18.

Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.

Petta CA, Faúndes A, Dunson TR, Ramos M, DeLucio M, Faúndes D, Bahamondes L.

Fertil Steril. 1998 Nov;70(5):817-20.

PMID:
9806559
19.

[Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].

Rossmanith WG, Wirth U, Gasser S, Thun B, Steffens D.

Zentralbl Gynakol. 1997;119(11):538-44. German.

PMID:
9480608
20.

The COX-2 inhibitor meloxicam prevents pregnancy when administered as an emergency contraceptive to nonhuman primates.

McCann NC, Lynch TJ, Kim SO, Duffy DM.

Contraception. 2013 Dec;88(6):744-8. doi: 10.1016/j.contraception.2013.09.006. Epub 2013 Sep 13.

PMID:
24120248
Items per page

Supplemental Content

Write to the Help Desk